Current Issue

Electronic pages

• Correspondence on ‘Statistical review: frequently given comments’ (24 March, 2021) Free

  Daisuke Waki, Masahiro Banno, Takashi Fujiwara
• Response to: ‘Correspondence on ‘Statistical review: frequently given comments’’ by Waki et al

  (24 March, 2021) Free

  Stian Lydersen
• Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’ (10 March, 2021)

  Shanoj K C, Sakir Ahmed, Veena Shenoy, Aparna R Menon, Sanjo Saijan, Sageer AS Babu, Padmanabha Shenoy
• Response to: ‘Correspondence on ‘SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease’’ by C et al

  (10 March, 2021)

  Kristin M D’Silva, Naomi Serling-Boyd, Tiffany Y-T Hsu, Jeffrey A Sparks, Zachary Scott Wallace
• Correspondence on ‘Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab’ (12 May, 2021)

  Desiree Tampe, Peter Korsten, Samy Hakroush, Martin Sebastian Winkler, Björn Tampe
• Response to: ‘Correspondence on ‘Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab’’ by Tampe et al

  (12 May, 2021)

  Marcia A Friedman, Kevin L Winthrop
• Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’ (26 April, 2021)

  Aimilios Kaklamanos, Panagiotis Karamichalos, Panayiotis G Vlachoyiannopoulos, Athanasios G Tzioufas
• Response to: ‘Correspondence on ‘Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study’’ by Kaklamanos et al

  (26 April, 2021)

  Sofia Ramiro, Rémy L M Mostard, Robert B M Landewé
• Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’ (27 April, 2021)

  Rashmi Roongta, Arghya Chattopadhyay, Alakendu Ghosh
• Response to: ‘Correspondence on ‘Onset of rheumatoid arthritis after COVID-19: coincidence or connected?’’ by Roongta et al

  (27 April, 2021)

  Veerle F A M Derksen, Diane van der Woude
• Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry’ (13 May, 2021)

  James Todd Rosenbaum, Michael H Weisman, Cassie Shafer, Elin Aslanyan, Richard A Howard, Kimberly Ogle, Hedley Hamilton, John D Reveille, Kevin L Winthrop, Dongseok Choi
• Response to: ‘Correspondence on ‘Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician reported registry’’ by Rosenbaum et al

  (13 May, 2021)

  Kimme L Hyrich, Martin Schäfer, Anja Strangfeld, Loreto Carmona, Laure Gossec, Elsa F Mateus, Saskia Lawson-Tovey, Milena Gianfrancesco, Philip C Robinson, Jinoos Yazdany, Pedro M Machado
• Correspondence to: ‘Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry’ by Gianfrancesco et al

  (19 August, 2020)

  Rachael Mary Flood, Richard Conway, Colm Kirby, Diana Gheta, David J Kane, Ronan H Mullan
• Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ (26 May, 2021) Free

  Tsung-Kun Lin, Lung-Fa Pan, Gwo-Ping Jong
• Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ (26 May, 2021) Free

  Zhen Gong, Fangjie Zhang
• Response to: ‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study’ by Gong and Zhang and Lin et al

  (26 May, 2021) Free

  Shahab Abtahi, Johanna H M Driessen, Andrea M Burden, Patrick C Souverein, Joop P van den Bergh, Annelies Boonen
• Correspondence on ‘Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine-learning-based model to assist the diagnosis of systemic lupus erythematosus’ (2 April, 2021) Free

  Ezgi Deniz Batu, Ummusen Kaya Akca, Ozge Basaran, Yelda Bilginer, Seza Ozen
• Response to: ‘Correspondence on ‘Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus’ by Batu et al

  (2 April, 2021) Free

  Christina Adamichou, George Bertsias
• Correspondence on: ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’ (31 March, 2021) Free

  Alojzija Hočevar, Aleš Ambrožič, Matija Tomšič
• Response to: ‘Correspondence on ‘What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern’’ by Hocevar et al

  (31 March, 2021)

  Philipp Gauckler, Erica L Bettac, Andreas Kronbichler
• Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised controlled trial’ (23 March, 2021) Free

  Liseth de Wolff, Suzanne Arends, Gwenny M Verstappen, Arjan Vissink, Frans G M Kroese, Hendrika Bootsma
• Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by de Wolff et al

  (2 April, 2021) Free

  Renaud Felten, Jacques-Eric Gottenberg
• Correspondence on ‘Warfarin use and risk of knee and hip replacements’ (13 May, 2021) Free

  Chao Cheng, Fangjie Zhang
• Response to: ‘Correspondence on ‘Warfarin use and risk of knee and hip replacements’’ by Cheng and Zhang (13 May, 2021) Free

  Tuhina Neogi, Christine Peloquin, Priyanka Ballal, Cindy Germaine Boer
• Paradoxical gastrointestinal effects of interleukin-17 blockers (28 September, 2020) Free

  Pankti Mehta, Able Lawrence, Amita Aggarwal